Summary
Islet cell antibodies were studied in 1,112 non-diabetic adults, 473 normal school children and 162 Type 1 (insulin-dependent) diabetic patients in a Japanese population. The prevalence of islet cell antibodies was 0.5%, 0.4% and 32%, respectively. Most islet cell antibodies positive subjects with Type 1 diabetes had short duration of the disease. No patients who had over 10 years from the onset had islet cell antibodies. Six non-diabetic adults with islet cell antibodies were followed for 4 years. Only one with Hashimoto's thyroiditis showed a diabetic pattern in her oral glucose tolerance test. However, none developed overt insulin-dependent diabetes until 1984. Two out of these six subjects continued to be positive for both islet cell antibodies and antithyroid antibodies or antinuclear antibodies. Islet cell antibodies in the remaining four patients disappeared during the second year. It is difficult to predict the onset of Type 1 diabetes by islet cell antibodies in non-diabetic individuals because they may be transient.
Article PDF
Similar content being viewed by others
References
Ofuji T, Ofuji N (1977) Autoimmune adrenalitis. Igaku-no-ayumi 102: 394–401 (Japanese)
Ibayashi H (1970) Etiology and symptoms of Addison's disease. Saishinigaku 25: 534–540 (Japanese)
Lendrum R, Walker G, Cudworth AG, Theophanides C, Pyke DA, Bloom A, Gamble DR (1976) Islet-cell antibodies in diabetes mellitus. Lancet 2: 1273–1276
Irvine WJ, McCallum CJ, Gray RS, Campbell CJ, Duncan LJP, Farquhar JW, Vaughan H, Morris PJ (1977) Pancreatic islet-cell antibodies in diabetes mellitus correlated with the duration and type of diabetes, coexistent autoimmune disease, and HLA type. Diabetes 26: 138–147
Del Prete GF, Betterle C, Padovan D, Erle G, Toffolo A, Bersahi G (1977) Incidence and significance of islet-cell antibodies in different types of diabetes mellitus. Diabetes 26: 909–915
Pujor-Borrell R, Richart C, Martin C, Martinez-Vazquez JM, Bottazzo GF (1978) Islet-cell antibodies in Spanish diabetics. Lancet 2: 268–269
Knowler WC, Bennet PH, Bottazzo GF, Doniach D (1979) Islet cell antibodies and diabetes mellitus in Pima Indians. Diabetologia 17: 161–164
Rodger B, Whittingham S, Martin FIR, Hawkins BR, Dawkins RL, Welborn TA (1980) A population survey of pancreatic islet cell antibodies. Clin Exp Immunol 39: 125–129
Neufeld M, Maclaren NK, Riley WJ, Lezatte D, Mclaughlin JW, Silverstein J, Rosenbloom AL (1980) Islet cell and other organspecific antibodies in U.S. Caucasians and Blacks with insulin-dependent diabetes mellitus. Diabetes 29: 589–592
Gorsuch AN, Spencer KM, Lister J, Wolf E, Bottazzo GF, Cudworth AG (1982) Can future Type 1 diabetes be predicted? Diabetes 31: 862–866
Bottazzo GF, Florin-Christensen A, Doniach D (1974) Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 2: 1279–1283
MacCuish AC, Barnes EW, Irvine WJ, Duncan LJP (1974) Antibodies to pancreatic islet cells in insulin dependent diabetics with coexistent autoimmune disease. Lancet 2: 1529–1533
Bottazzo GF, Dean BM, Gorsuch AN, Cudworth AG (1980) Complement-fixing islet-cell antibodies in Type 1 diabetes: possible monitors of active beta-cell damage. Lancet 1: 668–672
Notsu K, Note S, Nabeya N, Kuno S, Sakurami T (1983) Antinuclear antibodies in childhood diabetics. Endocrinol Japon 30: 469–473
National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28: 1039–1057
Sakurami T, Nagaoka K, Nabeya N, Imura H, Kuno S (1980) Islet-cell antibodies and HLA type in Japanese insulin-dependent diabetics. Endocrinol Japon 27: 149–152
Tunbridge WMG, Brewis M, French JM, Appleton D, Bird T, Clark F, Evered DC, Evans JG, Hall R, Smith P, Stephenson J, Young E (1981) Natural history of autoimmune thyroiditis. Br Med J 282: 258–262
Yoshida H, Amino N, Yagawa K, Umemura K, Satoh M, Miyai K, Kumahara Y (1978) Association of serum antithyroid antibodies with lymphocytic infiltration of the thyroid gland: Studies of seventy autopsied cases. J Clin Endocrinol Metab 46: 859–862
Irvine WJ, Gray RS, McCallum CJ (1976) Pancreatic islet-cell antibodies as a marker for asymptomatic and latent diabetes and prediabetes. Lancet 2: 1097–1102
Gorsuch AN, Spencer KM, Lister J, McNally JM, Deam BM, Bottazzo GF, Cudworth AG (1981) Evidence for a long pre-diabetic period in Type 1 (insulin-dependent) diabetes mellitus. Lancet 2: 1363–1365
Spencer KM, Tarn A, Dean BM, Lister J, Bottazzo GF (1984) Fluctuating islet-cell autoimmunity in unaffected relatives of patients with insulin-dependent diabetes. Lancet 1: 764–766
Helmke K, Otten A, Willems W (1980) Islet cell antibodies in children with mumps infection. Lancet 2: 211–212
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Notsu, K., Oka, N., Note, S. et al. Islet cell antibodies in the Japanese population and subjects with Type 1 (insulin-dependent) diabetes. Diabetologia 28, 660–662 (1985). https://doi.org/10.1007/BF00291971
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00291971